NEW YORK, May 1 – Genomica said Tuesday its first quarter revenues rose 20 percent to $444,000 compared with $370,000 in the same period last year.

Genomica’s operating expenses rose to $7.7 million for the quarter, up from $6.8 for the previous-year period, stemming from higher R&D and sales and marketing expenses. General and administrative expenses decreased to $2.1 million from $2.5 million for the first quarter of 2000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.